Högskolan i Skövde

his.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Targeting the epigenetic state of refractory and relapsing acute myeloid leukaemia
University of Skövde, School of Bioscience.
2021 (English)Independent thesis Advanced level (degree of Master (Two Years)), 30 credits / 45 HE creditsStudent thesis
Abstract [en]

Acute myeloid leukaemia (AML) is a heterogeneous group of myeloid lineage malignancies arising from a spectrum of mutations. AML is characterized by the uncontrolled proliferation of clonal cells, which are unable to properly differentiate into mature myeloid cells. The present day standard treatment of care for AML patients under 60 years of age is the “7+3” induction chemotherapy. The survival rate beyond 5 years has been maintained at 40%. Most AML patients older than 60 years are unable to tolerate this intensive cytotoxic induction regimen and are treated with hypomethylating drugs. The two-year relapse-free survival rate of these patients remains at 40% (exceptionally low) with a median survival of 6.5 months. Thus, novel therapeutic strategies are urgently needed to improve the overall survival of both young and elderly AML patients. Therefore, elucidating the molecular mechanisms underlying AML has been of prime importance in the development of efficacious targeted therapeutics to treat subtypes of this heterogeneous haematological malignancy. Next-generation sequencing has uncovered that the most frequently mutated class of genes in AML encode epigenetic modifiers, suggesting that alterations in the epigenetic landscape contribute to the development of AML. H3K27me3 is an epigenetic alteration of the Histone H3, one of the five principal histones involved in chromatin construction in eukaryotic cells. In refractory acute myeloid leukaemia, a study found an epigenetic relationship between the decreased abundance of the Polycomb related protein MTF2 and chemotherapy resistance. MTF2 loss hampered PRC2 complex expression and H3K27me3 deposition at numerous genes, including the major target gene MDM2, resulting in enhanced MDM2 expression, which depleted p53 and conferred chemoresistance. This study aimed to elucidate the epigenetic dysregulation in chemorefractory and chemoresponsive AML.     A systems biology methodology was utilized here. Two AML sample types were collected from the bone marrow of AML patients. The first sample (AML_4) had basal levels of the epigenetic modification H3K27me3 and basal levels of MTF2. The second sample (AML_1) had low levels of H3K27me3 and basal levels of MTF2. ATAC-seq (Assay for Transposase Accessible Chromatin with High-Throughput Sequencing) is a powerful tool for revealing chromatin accessibility across the genome. By probing hyperactive Tn5 transposase to a DNA sequence, ATAC-seq generates reads from cells representing accessible regions that correspond to nucleosome positioning and transcription factor binding sites. ATAC-seq was performed on AML_4 and AML_1. Bioinformatics analysis was conducted on the two ATAC-seq data to identify transcription factors with differential activity in each of the AML types. 36 transcription factors with significant differential activity were identified in AML_1 while 4 transcription factors were identified in AML_4. These results reveal higher epigenetic dysregulation in AML_1. These results reveal higher epigenetic dysregulation in AML_1 compared to AML_4. These transcription factors with significant activity in the different AML types would be combined with CHIP-seq and RNA-seq data thereafter used for gene regulatory network analysis of key AML genes to uncover the underlying mechanisms of the regulation of these genes. 

Place, publisher, year, edition, pages
2021. , p. 36
National Category
Bioinformatics and Systems Biology
Identifiers
URN: urn:nbn:se:his:diva-20703OAI: oai:DiVA.org:his-20703DiVA, id: diva2:1611908
External cooperation
William Stanford Laboratory ; The Ottawa Hospital Research Institute
Subject / course
Systems Biology
Educational program
Infection Biology - Master’s Programme 120 ECTS
Supervisors
Examiners
Available from: 2021-11-16 Created: 2021-11-16 Last updated: 2021-11-16Bibliographically approved

Open Access in DiVA

fulltext(2835 kB)290 downloads
File information
File name FULLTEXT01.pdfFile size 2835 kBChecksum SHA-512
0a9cdfc9b5bef3aa23b8ccfac8059002798ee2a546198566aa8d048ff46bfc2b247fa2516499d3e76258ab3a6533b1ab42443a3d673b02f1a64d905346fb4209
Type fulltextMimetype application/pdf

By organisation
School of Bioscience
Bioinformatics and Systems Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 290 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 864 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • apa-cv
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf